Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2023-02-06 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 6, 2023, addressed to stock exchanges, informing them about the schedule of an upcoming analyst/institutional investor meeting (conference call) on February 7, 2023. It explicitly states it is pursuant to SEBI regulations and contains no financial data or detailed report content. The document is an announcement of a meeting schedule rather than a financial report, earnings release, or transcript. Given the short length (1720 characters) and nature of the content, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories like Call Transcript or Investor Presentation, which would contain more detailed content. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2023-02-06 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) referencing Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure requirements. It mentions the attachment of newspaper advertisements of the company's financial results for the quarter and nine months ended December 31, 2022, published in newspapers on February 3, 2023. The document is essentially a notification or disclosure of the publication of financial results in newspapers, not the financial results report itself. The document length is 15,000 characters, but the content is primarily a short disclosure letter with attached newspaper ads. There is no detailed financial data or analysis within the text, only a statement that the financial results have been published in newspapers. This fits the pattern of a Regulatory Filing (RNS) as it is a regulatory disclosure announcement rather than the actual financial report or earnings release. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-02-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the availability of an audio recording of a conference call for Q3 & 9M-FY23 results. It references the SEBI regulations and provides a link to the recording on the company's website. The document does not contain any financial data or detailed transcript but merely announces the availability of the conference call audio recording. Given the short length (1450 characters) and the nature of the content, this is an announcement related to a conference call rather than the transcript itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a Call Transcript (CT) or Earnings Release (ER).
2023-02-02 English
Change in Director(s)
Regulatory Filings
2023-02-02 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated February 2, 2023, announcing the unaudited financial results for the quarter and nine months ended December 31, 2022. It contains consolidated performance highlights, financial overview tables, and management commentary on the quarter's results. The document is approximately 6,192 characters long, which is sufficient to include substantive financial data and analysis. It is not a full annual report (10-K) or an interim report in the traditional regulatory filing sense but is a quarterly earnings announcement with key financial highlights and commentary. The document is titled as a 'Press Release for Un-audited Financial Results' and includes detailed financial metrics such as revenue, EBITDA, PBT, and PAT for the quarter and year-to-date periods. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights. Therefore, the correct classification is Earnings Release (ER). Q3 2023
2023-02-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2022'. It is addressed to stock exchanges and mentions that the presentation is to be shared with analysts and investors. The content includes detailed financial highlights, key performance indicators, and operational data for Q3 FY23 and nine months ended December 31, 2022. The document is about 15,000 characters long, which is consistent with a detailed presentation rather than a brief announcement. The presence of forward-looking statements and disclaimers typical of investor presentations further supports this classification. It is not a full annual or quarterly report with comprehensive financial statements, but a presentation summarizing earnings results and business highlights. Therefore, the document fits the category of an Investor Presentation (IP).
2023-02-02 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.